Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy

Pharmacological Research

Volumn 47, Issue 6, 2003, Pages 493-499

  Gallelli, L ^a   Ferreri, G ^a   Colosimo, M ^a   Pirritano, D ^a   Flocco, M A ^a   Pelaia, G ^a   Maselli, R ^a   De Sarro, G B ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Adverse drug reactions; Bronchodilators; Clinical records; Hospitalised patients; Pulmonary

Indexed keywords

AMBROXOL; BECLOMETASONE; BRONCHODILATING AGENT; BUDESONIDE; FLUTICASONE; FORMOTEROL; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BRONCHODILATATION; CHILD; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HEARING IMPAIRMENT; HEART ATRIUM FIBRILLATION; HUMAN; ITALY; KIDNEY INJURY; LEUKOPENIA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NERVE INJURY; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SIDE EFFECT; TACHYCARDIA; THRUSH; VISUAL IMPAIRMENT;

EID: 0037624839     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00003-3     Document Type: Article

References (36)

1. Moore N., Biour M., Paux G., Loupi E., Begaud B., Boismare F.et al. Adverse drug reaction monitoring: doing it the French way. Lancet. 2:1985;1056-1058.
2. Lee C.E., Zembower T.R., Fotis M.A., Postelnick M.J., Greenberger P.A., Peterson L.R.et al. The incidence of antimicrobial allergies in hospitalised patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch. Intern. Med. 160:2000;2819-2822.
3. Bordet R., Gautier S., Le Louet H., Dupuis B., Caron J. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur. J. Clin. Pharmacol. 56:2001;935-941.
4. Meyboom R.H., Lindquist M., Egberts A.C. An ABC of drug-related problems. Drug Saf. 22:2000;415-423.
5. Classen D.C., Pestotnik S.L., Evans R.S., Lloyd J.F., Burke J.P. Adverse drug events in hospitalised patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 277:1977;301-306.
6. Buajordet I., Ebbesen J., Erikssen J., Brors O., Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J. Intern. Med. 250:2001;327-341.
7. Rawlins M.D. Spontaneous reporting of adverse drug reactions. I: the data. Br. J. Clin. Pharmacol. 26:1988;7-11.
8. Brewer T., Colditz G.A. Postmarketing surveillance and adverse drug reactions. JAMA. 281:1999;824-829.
9. Novotny J., Novotny M. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen. Physiol. Biophys. 18:1999;126-139.
10. Kramer M.S., Leventhal J.M., Hutchinson T.A., Feinstein A.R. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA. 242:1979;623-632.
11. Karch F.E., Lasagna L. Toward the operational identification of adverse drug reactions. Clin. Pharmacol. Ther. 21:1977;247-254.
12. Colt H.G., Shapiro A.P. Drug-induced illness as a cause for admission to a community hospital. J. Am. Geriat. Soc. 37:1989;323-326.
13. Carbonin P., Pahor M., Bernabei R., Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalised medical patients? J. Am. Geriat. Soc. 39:1991;1093-1099.
14. Hallas J., Harvald B., Gram L.F., Grodum E., Brosen K., Haghfelt T.et al. Drug related hospital admissions: the role of definitions and intensity of data collection and the possibility of prevention. J. Intern. Med. 228:1990;83-90.
15. Royer RJ. Mechanism of action of adverse drug reactions: an overview. Pharmacoepidemiol Drug Saf 1997; (Suppl 3):S43-50.
16. Meyboom R.H., Egberts A.C., Edwards I.R., Hekster Y.A., de Koning F.H., Gribnau F.W. Principles of signal detection in pharmacovigilance. Drug Saf. 16(6):1997;355-365.
17. Hutchinson T.A., Leventhal J.M., Kramer M.S., Karch F.E., Lipman A.G., Feinstein A.R. An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. JAMA. 242:1979;633-638.
18. Edwards I.R., Biriell C. Harmonisation in pharmacovigilance. Drug Saf. 10:1994;93-102.
19. Gallelli L., Ferreri G., Colosimo M., Pirritano D., Guadagnino L., Pelaia G.et al. Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: a six-year retrospective study. Pharm. Res. 46:2002;395-400.
20. Lindquist R., Gersema L.M. Understanding and preventing adverse drug reactions. AACN Clin. Issues. 9:1998;119-128.
21. Pilzer J.D., Burke T.G., Mutnick A.H. Drug allergy assessment at an university hospital and clinic. Am. J. Health Syst. Pharm. 53:1996;2970-2975.
22. Morales-Olivas F.J., Martinez-Mir I., Ferrer J.M., Rubio E., Palop V. Adverse drug reactions in children reported by means of the yellow card in Spain. J. Clin. Epidemiol. 53:2000;1076-1080.
23. Kraaij van D.J.W., Haagsma C.J., Go I.H., van Kraaij D.J. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Neth. J. Med. 44:1994;166-173.
24. Mannesse C.K., Derkx F.H., De Ridder M.A.J., In T., Veld M., van der Cammen T.J.M. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 29:2000;35-39.
25. Veehof L.J., Stewart R.E., Meyboom-de Jong B., Haaijer-Ruskamp F. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur. J. Clin. Pharmacol. 55:1999;533-536.
26. Beyth R.J., Shorr R.I. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging. 14:1999;231-239.
27. Cooper J.W. Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J. Am. Geriat. Soc. 44(2):1996;194-197.
28. Heininger-Rothbucher D., Bischinger S., Ulmer H., Pechlaner C., Speer G., Wiedermann C.J. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation. 49:2001;283-288.
29. de la Hoz B., Perez C., Tejedor M.A., Lazaro M., Salazar F., Cuevas M. Immediate adverse reaction to aminophylline. Ann. Allergy. 71:1993;452-454.
30. Yoshizawa A., Araki Y., Kobayashi N., Kudo K. A case of aminophylline hypersensitivity reaction due to ethylenediamine. Arerugi. 48:1999;1206-1211.
31. Svensson C.K., Cowen E.W., Gaspari A.A. Cutaneous drug reactions. Pharmacol. Rev. 53:2001;357-379.
32. Hutchinson T.A., Flegel K.M., Kramer M.S., Leduc D.G., Kong H.H. Frequency, severity and risk factors for adverse drug reactions in adult out-patients: a prospective study. J. Chronic. Dis. 39:1986;533-542.
33. Bigby M. Rates of cutaneous reactions to drugs. Arch. Dermatol. 137:2001;765-770.
34. Smith C.C., Bennett P.M., Pearce H.M., Harrison P.I., Reynolds D.J.M., Aronson J.K.et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicine. Br. J. Clin. Pharmacol. 42:1996;423-429.
35. 2-agonists and corticosteroids. Eur. Respir. J. 19:2002;182-191.
36. Facchini G., Antonicelli L., Cinti B., Bonifazi F., Massei V. Paradoxical bronchospasm and cutaneous rash after metered-dose inhaled bronchodilators. Monaldi. Arch. Chest Dis. 51:1996;201-203.